Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07171684 · ClinicalTrials.gov registry record · NA
Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)
A NA study of Gestational Diabetes and Diabetes in Pregnancy, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 176
- Enrollment target
- 1
- Study location
NCT07171684: Recruiting NA study of Gestational Diabetes and Diabetes in Pregnancy, sponsored by Rutgers, The State University of New Jersey.
NCT07171684 is a NA study of Gestational Diabetes and Diabetes in Pregnancy that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 176 participants, below the 318-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07171684, a NA study of Gestational Diabetes and Diabetes in Pregnancy, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 176 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to see if diabetes in pregnancy can be treated with once daily dosing of insulin instead of once daily dosing plus insulin with meals. The main question this study aims to answer is: 1. Can a once daily dose of long-acting insulin control blood sugars as well as long-acting insulin plus meal-time insulin? 2. Do babies born to mothers who take one dose of long-acting insulin have more complications after birth than babies born to mothers who take long-acting and meal-time insulin? Researchers will compare one dose of long-acting insulin per day to this plus three doses of short-acting insulin with each meal to see if blood sugars are controlled. Participants will send their blood sugar logs to the study staff weekly, instead of to their OB/GYN, for adjustments to their insulin dosing.
Primary Outcome
NICU admission, neonatal hyperglycemia, neonatal hypoglycemia, large for gestational age, shoulder dystocia, hyperbilirubinemia stillbirth, and neonatal death
Conditions Studied
Interventions
- DRUG Insulin glargine alone
- DRUG Insulin glargine + insulin lispro
Study Locations (1)
New Jersey
- Robert Wood Johnson Univeristy Hospital - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2025-11-26 |
| Est. Completion | 2027-05-15 |
| Phase | NA |
What NCT07171684 shows while recruiting
NCT07171684 is an interventional study that assigns participants to a tested intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, below the 318-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (45% lower).
The record links to 2 conditions, with Gestational Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Insulin glargine alone is the first listed.
NCT07171684 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT07171684 about?
NCT07171684 is a clinical study titled "Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)". The goal of this clinical trial is to see if diabetes in pregnancy can be treated with once daily dosing of insulin instead of once daily dosing plus insulin with meals. The main question this study aims to answer is: 1. Can a once daily dose of long-acting insulin control blood sugars as well as l...
What is the current status of trial NCT07171684?
This trial is currently recruiting. It is a NA study. The enrollment target is 176 participants. The study started on 2025-11-26. Estimated completion is 2027-05-15.
What conditions does trial NCT07171684 study?
This clinical trial studies the following conditions: Gestational Diabetes, Diabetes in Pregnancy.
What interventions are being tested in trial NCT07171684?
The interventions under investigation include: Insulin glargine alone (DRUG), Insulin glargine + insulin lispro (DRUG).
Who is sponsoring clinical trial NCT07171684?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07171684 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07171684's enrollment target sits among peer trials
176 15th of 41 higher than 27 of 41 other Gestational Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gestational Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nutrition Optimization and Community Upliftment for Postpartum Recovery
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
RECRUITING · NA
-
Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI